91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
In this article, 91黑料’s Andreas Dreps and Martin Lachs discuss the logistical considerations in
?BioPharm International
-
In this article from International Biopharmaceutical Industry, Dr. Chad Galderisi, Vice President and Global Medical Director for 91黑料 Specialty Laboratories explores how can be used to provide critical and complementary data that is needed to bring .
Published by Journal Volume 6 Issue 3
-
Learn more about the in this article.
? Huber, B.; Joeckel, T. Challenges of Expanding CAR-T Cell Therapy into Solid Tumors. BioPharm International 2023, 36 (5), 22–23,27
-
This article looks at the , the challenges biopharma companies face in running clinical trials and tips on how to surmount those obstacles.
-
In this article,Brian HuberandTamie Joeckel,
-
Brandon Fletcher, Principal, Cell and Gene Therapy, offers his insights on .
-
Brian Huber, Vice President, Drug Development Services, considers .
-
how glycomics is joining genomics and proteomics in the study of disease mechanisms and the development of novel therapeutics.
-
Tamie Joeckel discusses .
-
In this webinar review some of the factors investigational teams should now consider in the planning and execution of cell and gene therapy development programs.
